ANTIMICROBIAL AGENTS
Page 1
Title: Antimicrobial Agents
Babs de Villiers2025187
Page 2
Definition and Aim
Objective: Treat infections with agents to which the causative organism is sensitive.
Ideal Agent: Must inhibit growth of the organism with minimal adverse effects on host cells.
Page 3
Historical Context
Discovery: First antibiotic discovered by Alexander Fleming in 1928.
Research Context:
Organism Studied: Staphylococcus aureus.
Fungal Contribution: Spores of Penicillium notatum led to the production of penicillin which inhibited S. aureus growth.
Isolation of Substance: Achieved by Ernst Chain & Sir Howard Florey in 1939.
Page 4
Discovery of Penicillin
Experiments:
Original by Fleming (1928): Lysis of staphylococci under penicillium colony.
Modern techniques showcase zones of inhibition on agar plates.
Page 5
Characteristics of Good Antimicrobial Agents
Essential Traits:
Lack allergic properties.
Relevant spectrum of activity.
Effective tissue penetration.
Minimal development of resistance.
Minimal or no harm to the patient.
Page 6
Patient Education for Proper Use
Focus Areas:
Aims of antibiotic therapy.
Mechanisms of antibiotic action.
Awareness of side effects.
Risks of indiscriminate use.
Page 7
Indications for Antibiotic Treatment
Types of Treatment:
Presumptive (empiric): Based on clinical experience before diagnosis confirmation.
Chemoprophylaxis: Based on infection risk.
Targeted/Definitive: Based on laboratory results.
Page 8
Situations Requiring Chemoprophylaxis
Appropriate Cases:
Large bowel surgery to prevent gut flora infection.
Major orthopedic/cardiac surgeries.
Patients with histories of rheumatic heart disease or meningococcal meningitis.
Travelers to malaria-endemic areas.
Page 9
Key Antimicrobial Properties
Considerations:
Spectrum (wide/narrow).
Mechanism (bacteriostatic/bactericidal).
Penetration ability.
Resistance potential.
Side effects, particularly in pregnancy and childhood.
Page 10
Definitions of Key Terms
Antibiotic: Chemical substance by microorganisms that kills/inhibits other microbes.
Antimicrobial Agent: Includes naturally produced, chemically synthesized, and semi-synthetic substances.
Page 11
Further Definitions
Chemotherapeutic Agent: Used against micro-organisms internally and externally.
Bactericidal Agent: Kills bacteria, often crucial for immunocompromised patients.
Bacteriostatic Agent: Inhibits bacterial growth, needing host response for ultimate effect.
Page 12
Mechanisms of Action
Bactericidal vs. Bacteriostatic:
Bactericidal kills bacteria; crucial for severe infections.
Bacteriostatic inhibits growth; relies on host immune system.
Page 13
Effects of Antibiotics
Outcome without Antibiotics: Bacteria multiply.
Bacteriostatic: Prevents bacterial multiplication.
Bactericidal: Kills bacteria.
Page 14
Examples of Antimicrobial Agents
Bacteriostatic: Chloramphenicol, Erythromycin, Tetracyclines.
Bactericidal: Aminoglycosides, Beta-lactams, Vancomycin.
Page 15
Mechanism of Selective Toxicity
Targeted Action: Specific to microorganism structures without harming host (e.g. nucleoid, ribosome, cell wall).
Page 16
Overview of Chemotherapy
General Definition: All antimicrobial agents and cancer treatment drugs.
Minimal Inhibitory Concentration (MIC): Lowest concentration of agent inhibiting organism growth.
Page 17
Susceptible vs. Resistant Organisms
Definitions:
Susceptible: Organisms inhibited/killed by agents.
Resistant: Organisms with reduced antimicrobial effectiveness.
Page 18
Spectrum of Activity
Categories:
Narrow Spectrum: Effective against few pathogens.
Broad Spectrum: Effective against many types.
Page 19
Drug Interactions
Synergism vs. Antagonism:
Synergism: Combined effects greater than individual (1 + 1 = 6).
Antagonism: Canceled effects (3 + 4 = 0).
Page 20
Synergistic Effects
Example: Aminoglycoside + Cell Wall Synthesis Inhibitor results in increased bacterial death.
Page 21
Sources of Antimicrobial Agents
Natural: Antibiotics from microbes (e.g. penicillin).
Chemically Synthesized: e.g., sulphonamides.
Molecular Modifications: Enhancing efficacy and spectrum.
Page 22
Penicillin Structure
Key Components:
R Group affects drug properties and activity.
Page 23
Historical Context
Key Findings in Timeline: Significant discoveries and developments in antibiotic production over decades.
Page 24
Biological Origin of Antibiotics
Produced from: Filamentous fungi and spore-producing bacteria.
Page 25
Beta-lactam Antibiotics
Notable Types: Penicillin and Cephalosporin, both produced by specific molds.
Page 26
Non Beta-lactam Antibiotics
Key Examples:
Tetracycline, Aminoglycosides, Macrolides, Chloramphenicol from Streptomyces.
Page 27
Timeline of Antibiotic Discoveries
Major Discoveries: Insights into the history and evolution of antibiotics from the 1940s to 2000s.
Page 28
Life Cycle of Sporulating Actinomycetes
Stages: From vegetative growth to spore dispersal and antibiotic production.
Page 29
Polypeptide Antibiotics
Examples: Polymyxin B and colistin, produced by Bacillus species.
Page 30
Types of Antimicrobial Agents
Categories:
Antibacterial, antifungal, antiparasitic, antiviral agents.
Page 31
Routes of Administration
Methods: Oral, intravenous, intramuscular, topical, vaginal, rectal.
Page 32
Target Sites for Action
Focus Areas: Cell wall, membrane, ribosomes, nucleic acids, metabolic pathways.
Page 33
Cell Wall Synthesis Inhibition
Importance: Peptidoglycan layer essential for bacterial rigidity and shape, targeted by antibiotics.
Page 34
Differences in Gram Bacteria
Gram + vs. Gram -: Variability in the thickness of peptidoglycan layer.
Page 35
Structure of Peptidoglycan
Composition: Sugars and amino acids create a mesh-like cell wall.
Page 36
Glycan Strand Structure
Linkages: Cross-links between peptide chains provide structural integrity.
Page 37
Beta-lactam Mechanism
Action Mechanism: Interference in peptidoglycan production leads to bacterial lysis and death.
Page 38
PBP Interaction
Targeting Mechanism: Beta-lactam agents bind to Penicillin Binding Proteins (PBPs) to inhibit cell wall synthesis.
Page 39
Mechanism of Action of Beta-lactams
Inhibitory Mechanism: Block transpeptidase activity essential for cell wall cross-linking, leading to bacterial death.
Page 40
Resistance of Cell Wall-deficient Organisms
Examples: Mycoplasma and Ureaplasma are resistant to beta-lactams and glycopeptides.
Page 41
Types of Penicillins
Varieties: Include amoxicillin, ampicillin, methicillin, with different spectrum effectiveness.
Page 42
Structure of Beta-lactam Agents
Essence of Activity: Presence of a beta-lactam ring is crucial for function.
Page 43
Beta-lactamase Production
Defensive Mechanism: Enzyme produced by certain bacteria like S. aureus to degrade antibiotics.
Page 44
Penicillin Structural Variants
Variation in Drug Structure: Notable antibiotics with varying R Groups affecting efficacy and action.
Page 45
Clavulanic Acid Function
Role: Inhibitor of beta-lactamase, enhancing effectiveness when combined with other beta-lactam antibiotics.
Page 46
Interaction of Clavulanic Acid with Penicillin
Mechanism: Prevents degradation of beta-lactam ring, preserving antibiotic action.
Page 47
Glycopeptides Action
Targeting Mechanism: Disrupt iron chains in peptidoglycan, leading to bacterial cell death.
Page 48
Other Cell Wall Inhibitors
Key Agents: Isoniazid, ethambutol, and bacitracin impact mycobacterial cell walls.
Page 49
Membrane Action Antibiotics
Mechanism of Action: Polymyxin B and colistin target bacterial membranes leading to cell death.
Page 50
Protein Synthesis Inhibition
Key Groups: Aminoglycosides, tetracyclines, macrolides, affect ribosomes to halt protein synthesis.
Page 51
Overview of Protein Synthesis
Process: Involves mRNA, tRNA, and ribosome action to create proteins.
Page 52
Nucleic Acid Synthesis Inhibitors
Fluoroquinolones: Inhibit DNA gyrase for replication, with varying efficacy across generations.
Page 53
Generations of Fluoroquinolones
Categories: Progression from first to fourth generation targeting various bacterial spectra.
Page 54
RNA Synthesis Inhibition
Agents: Rifampin inhibits RNA polymerase, crucial for tuberculosis treatment.
Page 55
Metabolic Pathway Inhibitors
Examples: Sulfonamides and trimethoprim block folic acid synthesis, often used in combination for enhanced action.
Page 56
Action on Folate Synthesis
Pathway Steps: Key reactions disrupted by sulfonamides and trimethoprim leading to nucleic acid synthesis inhibition.
Page 57
Mechanisms of Protein Synthesis Inhibitors
Binding Sites: Various antibiotics target specific sites on the 30S or 50S ribosomal subunits.
Page 58
Challenges in TB Treatment
Obstacles: Waxy layer, intracellular location, and slow growth rate complicate therapy.
Page 59
First-Line TB Treatment Regimen
Regimen Overview: Combination of four agents administered daily for effective treatment.
Page 60
DOTS Strategy in TB Control
Definition: Directly Observed Treatment Short-course to promote adherence and prevent resistance.
Page 61
TB Treatment Durations
Pulmonary vs Extrapulmonary: Different durations of treatment based on disease types.
Page 62
Management of Drug-Resistant TB
MDR and XDR TB: Definition and treatment strategies involving complex drug combinations.
Page 63
Antifungal Agents Mechanism
Target: Ergosterol in fungal cell membranes, influencing permeability.
Page 64
Antiparasitic Agents Functions
Action Mechanisms: Drugs like mebendazole inhibit microtubule synthesis, while metronidazole forms unstable DNA.
Page 65
Challenges in Antiviral Therapy
Key Issues: Intracellular nature, host machinery utilization, and toxicity of antiviral drugs.
Page 66
Targets for Antiviral Agents
Focus Areas: Key stages in viral life cycles, from attachment to release of particles.
Page 67
HIV Targeted Antiviral Agents
Examples: Inhibition of reverse transcriptase and protease by AZT and nevirapine.
Page 68
Additional Antiviral Considerations
Common Targets: Include various viruses such as herpes and influenza.
Page 69
Resistance Mechanisms
Types: Natural resistance due to lack of targets or enzymatic degradation; acquired resistance through mutation or gene transfer.
Page 70
Biofilm Formation
Description of Biofilm: Structure protects bacteria from antibiotic penetration.
Page 71
Mechanisms of Acquired Resistance
Sources and Changes: Mutations or acquisition of resistance genes through plasmids and transposons.
Page 72
Acquisition Routes of Resistance
Mechanisms: Transformation, transduction, conjugation, and mutation pathways for resistance development.
Page 73
Examples of Resistance Mechanisms
Specific Cases: Biofilms, efflux pumps, and enzyme activity impeding antibiotic efficacy.
Page 74
Rational Use of Antibiotics
Combination Therapy Benefits: Enhanced effect, increased coverage, and prevention of resistance.
Page 75
Antibiotics in Food Supply
Usage: Common in animal feeds for infection prevention and growth promotion; risks of resistant strains in humans.
Page 76
Inappropriate Use Concerns
Common Issues: Misuse in viral infections, lack of supervision, and unnecessary prescriptions.
Page 77
Dangers of Indiscriminate Use
Consequences: Includes hypersensitivity, changes in flora, toxicity, and resistant strain development.
Page 78
Strategies to Reduce Abuse
Approaches: Avoid unnecessary prescriptions, especially for viral illnesses; patient and public education.
Page 79
Role of Microbiology Laboratories
Functions: Guide choice of antimicrobials, monitor treatment efficacy via susceptibility testing.
Page 80
Tests for Antimicrobial Susceptibility
Purpose: Determines sensitivity or resistance of microorganisms to antibiotics.
Page 81
Antimicrobial Susceptibility Testing
Methods: Classification of organisms as sensitive or resistant; establish minimal inhibitory concentration.
Page 82
Disc Diffusion Method
Overview: A method to classify organisms based on susceptibility to the tested antimicrobial agent.
Page 83
Determining MIC
Test Methods: Include dilution tests (broth and agar) to determine the minimal inhibitory concentration.
Page 84
E-Test Methodology
Procedure: Involves determining the MIC using an antibiotic strip on an agar plate.
Page 85
Molecular Resistance Detection Techniques
Advanced Methods: PCR, DNA sequencing, hybridization assays for resistance identification.
Page 86
Closing Note
Thank You for Learning!